Drug Type saRNAs |
Synonyms RAG-1C |
Target |
Action inhibitors |
Mechanism CDKN1A inhibitors(cyclin dependent kinase inhibitor 1A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Vitreoretinopathy, Proliferative | IND Approval | China | 31 Mar 2025 |





